Augmedix, Inc.

AUGX

US05105P1075

Business Support Services

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-31 EDT			5-day change	1st Jan Change
0.9181 ^USD	-8.14%		-19.46%	-84.31%

05-29	Augmedix Appoints Alex Stinard as Chief Clinical AI Officer	CI
05-14	Maxim Downgrades Augmedix to Hold From Buy	MT

Augmedix, Inc. Announces Management Changes

October 09, 2020 at 03:13 pm

Augmedix, Inc. Aanounced Mark Tompkins and Ian Jacobs resigned from board of directors, and Jennifer Carter was appointed to board of directors.

Latest news about Augmedix, Inc.

Augmedix Appoints Alex Stinard as Chief Clinical AI Officer	05-29	CI
Maxim Downgrades Augmedix to Hold From Buy	05-14	MT
B. Riley Adjusts Price Target on Augmedix to $3 From $5.50, Keeps Buy Rating	05-14	MT
Top Premarket Decliners	05-14	MT
Investors Await Key Inflation Data as US Futures Tread Water in Premarket Session	05-14	MT
Evercore ISI Downgrades Augmedix to In Line From Outperform, Price Target is $1.50	05-14	MT
Transcript : Augmedix, Inc., Q1 2024 Earnings Call, May 13, 2024	05-13
Augmedix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Earnings Flash (AUGX) AUGMEDIX Reports Q1 Revenue $13.5M, vs. Street Est of $13.4M	05-13	MT
Augmedix, Inc. Provides Revenue Guidance for the Year 2024	05-13	CI
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments	04-24	CI
Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing	04-12	MT
North American Morning Briefing : Traders Await -2-	04-10	DJ
Augmedix, Inc. Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care	04-09	CI
Augmedix Insider Sold Shares Worth $454,454, According to a Recent SEC Filing	04-05	MT
Augmedix Insider Sold Shares Worth $380,108, According to a Recent SEC Filing	04-04	MT
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide	04-04	CI
Top Midday Gainers	03-19	MT
Evercore ISI Adjusts Price Target on Augmedix to $4.50 From $6.50, Maintains In-Line Rating	03-19	MT
Augmedix Shares Surge 15% Premarket Tuesday as Revenue Growth Beats Expectations, Gross Margins Expand in Q4	03-19	MT
Transcript : Augmedix, Inc., Q4 2023 Earnings Call, Mar 18, 2024	03-18
Earnings Flash (AUGX) AUGMEDIX Reports Q4 Revenue $12.7M, vs. Street Est of $12.4M	03-18	MT
Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-18	CI
Augmedix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI
Augmedix Provides Revenue Guidance for the Year 2024	03-18	CI

Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patientâs health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Sector

Business Support Services

Calendar

2024-06-05 - William Blair Growth Stock Conference - Fireside Chat

More about the company

Income Statement Evolution

More financial data

Ratings for Augmedix, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.9181 USD

Average target price

3.333 USD

Spread / Average Target

+263.07%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Business Support Services

	1st Jan change	Capi.
AUGMEDIX, INC.	-84.31%	44.96M
CINTAS CORPORATION	+12.50%	68.79B
JACOBS SOLUTIONS INC.	+7.35%	17.45B
BUREAU VERITAS SA	+20.68%	13.58B
RB GLOBAL, INC.	+8.66%	13.35B
INTERTEK GROUP PLC	+12.48%	9.8B
TELEPERFORMANCE SE	-20.94%	6.74B
GENPACT LIMITED	-4.74%	5.95B
MAXIMUS, INC.	+2.67%	5.23B
EXLSERVICE HOLDINGS, INC.	-3.21%	4.85B

Other Business Support Services

Augmedix, Inc.

Equities

AUGX

US05105P1075

Business Support Services

Augmedix, Inc. Announces Management Changes

Latest news about Augmedix, Inc.

Chart Augmedix, Inc.

Company Profile

Income Statement Evolution

Ratings for Augmedix, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Business Support Services